Medicare Enrolled

Dr. Julie Patel, M.D.

Allergy Physician · Houston, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
12000 RICHMOND AVE, Houston, TX 77082
7137900900
Registered in NPPES since 2006
NPI: 1629084397 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Julie Patel is an allergy physician in Houston, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 2,608 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Patel received a total of $23,708 from 51 pharmaceutical and/or device companies across 624 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 2,608 Medicare services $23,708 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
2,608
Medicare services
Bottom 45% in TX for allergy physician
Not available
Unique patients (not deduplicated)
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 1,860 $18 $34
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
316 $54 $160
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
254 $95 $210
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
97 $66 $181
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
44 $8 $30
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
21 $122 $320
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
16 $136 $280
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$23,708
Total received (2018-2024)
Avg $3,387/year across 7 years
Top 3% in TX for allergy physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
624
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,466
2023
$1,997
2022
$1,890
2021
$1,450
2020
$5,290
2019
$8,415
2018
$2,200

Payments by company (2024)

Amgen Inc.
$443
Janssen Biotech, Inc.
$204
AstraZeneca Pharmaceuticals LP
$197
ABBVIE INC.
$169
Grifols USA, LLC
$163
Johnson & Johnson Health Care Systems Inc.
$150
GENZYME CORPORATION
$149
PFIZER INC.
$136
CSL Behring
$136
UCB, Inc.
$133
Takeda Pharmaceuticals U.S.A., Inc.
$105
Fresenius Kabi USA, LLC
$82
Aurinia Pharma U.S., Inc.
$71
BioCryst US Sales Co., LLC
$68
Pharming Healthcare, Inc.
$67
Novartis Pharmaceuticals Corporation
$46
Mallinckrodt Hospital Products Inc.
$34
E.R. Squibb & Sons, L.L.C.
$32
Alexion Pharmaceuticals, Inc.
$23
TerSera Therapeutics LLC
$22
Radius Health, Inc.
$19
Organon Llc
$16
Top 3 companies account for 34.2% of 2024 payments
All-time payments by company (2018-2024) ›
BioCryst Pharmaceuticals, Inc.
$3,490
Pharming Healthcare, Inc.
$3,326
Cardinal Health 108, LLC
$2,370
CSL Behring
$1,947
Amgen Inc.
$1,658
PFIZER INC.
$1,109
GlaxoSmithKline, LLC.
$706
Grifols USA, LLC
$640
ABBVIE INC.
$636
Novartis Pharmaceuticals Corporation
$623
GENZYME CORPORATION
$613
UCB, Inc.
$523
AstraZeneca Pharmaceuticals LP
$511
Aurinia Pharma U.S., Inc.
$459
Lilly USA, LLC
$437
Janssen Biotech, Inc.
$434
Genentech USA, Inc.
$408
Regeneron Healthcare Solutions, Inc.
$345
Takeda Pharmaceuticals U.S.A., Inc.
$302
BioCryst US Sales Co., LLC
$287
Johnson & Johnson Health Care Systems Inc.
$279
AbbVie Inc.
$248
Teva Pharmaceuticals USA, Inc.
$247
AbbVie, Inc.
$214
Shire North American Group Inc
$179
Radius Health, Inc.
$177
Mallinckrodt Hospital Products Inc.
$169
ALK-Abello, Inc
$146
Optinose US, Inc.
$125
Celgene Corporation
$120
Cardinal Health 110 LLC
$100
E.R. Squibb & Sons, L.L.C.
$91
Ethicon US, LLC
$83
Fresenius Kabi USA, LLC
$82
Mallinckrodt LLC
$80
Horizon Therapeutics plc
$75
Mallinckrodt Enterprises LLC
$70
ADMA BioManufacturing LLC
$65
Circassia Pharmaceuticals Inc
$55
MEDEXUS PHARMA, INC.
$47
Horizon Pharma plc
$43
Alexion Pharmaceuticals, Inc.
$37
Antares Pharma, Inc.
$22
TerSera Therapeutics LLC
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Octapharma USA, Inc.
$17
Organon Llc
$16
LEO Pharma Inc.
$15
Incyte Corporation
$15
DePuy Synthes Sales Inc.
$13
Flexion Therapeutics, Inc.
$11
Top 3 companies account for 38.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADBRY · AIRSUPRA · Actemra · BENLYSTA · Bimzelx · CIBINQO · CINQAIR · COSENTYX · CUTAQUIG · CUVITRU · CYLTEZO · Cimzia · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EUCRISA · EVENITY · EVUSHELD · Enbrel · FASENRA · FIRAZYR · Gamunex-C · HADLIMA · HUMIRA · HYQVIA · Haegarda · Hizentra · Humira · IDACIO · ILARIS · KEVZARA · KRYSTEXXA · Kcentra · LUPKYNIS · NIOX VERO · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORENCIA · ORLADEYO · ORTHOVISC · Odactra · Orladeyo · Otezla · Otrexup · PANZYGA · Prolia · QULIPTA · Quzyttir · RAYOS · REMICADE · RINVOQ · RUCONEST · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TAKHZYRO · TALTZ · TAVNEOS · TEZSPIRE · TREMFYA · Truxima · Tymlos · UBRELVY · Uloric · VRAYLAR · XELJANZ · Xembify · Xhance · Xolair · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an allergy physician in Houston?
Compare allergy physicians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse allergy physicians nearby

Geographic Context

Allergy physicians in nearby ZIP areas
18
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE WEST
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Patel is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Patel performed 1,860 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $23,708 from 51 companies across 624 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other allergy physicians in Houston?
Dr. Patel's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →